Jian Chen

发表

APOC2 accelerates colorectal cancer progression via modulating lipid metabolism and transcriptional activity of PHF8

Hua-mei Tang, Zhihai Peng, Huijun Lu, 2019, bioRxiv.

RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial–mesenchymal transition and promotes metastasis of colorectal cancer

Xin Zhang, Gang Wu, L. Zhong, 2019, Cell Death & Disease.

Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer

Hua-mei Tang, Zhihai Peng, Xiao Wang, 2015, Journal of Experimental & Clinical Cancer Research.

The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy

Hua-mei Tang, Zhihai Peng, Xiao Wang, 2021, Oncogene.

Loss of SHMT2 mediates 5-FU chemoresistance by inducing autophagy in colorectal cancer

Hua-mei Tang, Zhihai Peng, Xiao Wang, 2019, bioRxiv.

Overexpression of RBBP6, Alone or Combined with Mutant TP53, Is Predictive of Poor Prognosis in Colon Cancer

Hua-mei Tang, Zhihai Peng, Zehua Wu, 2013, PloS one.

Zinc-α-2-Glycoprotein: A Candidate Biomarker for Colon Cancer Diagnosis in Chinese Population

Fudong Yu, Senlin Zhao, Hua-mei Tang, 2014, International journal of molecular sciences.

Metalloproteases meprin-ɑ (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer

Fudong Yu, Senlin Zhao, Hua-mei Tang, 2016, BMC Cancer.

PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy

Fudong Yu, Senlin Zhao, Hua-mei Tang, 2014, Oncotarget.

RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer

Hong Zhang, Gang Wu, L. Zhong, 2018, Cancer science.

PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy

Fudong Yu, Senlin Zhao, Hua-mei Tang, 2014, OncoTarget.